Subcutaneous Immunoglobulin for Primary and Secondary Immunodeficiencies: an Evidence-Based Review

被引：0
|
作者：
Jenny Lingman-Framme
Anders Fasth
机构：
[1] Halland Hospital,Department of Pediatrics
[2] University of Gothenburg,Department of Pediatrics
来源：
Drugs | 2013年 / 73卷
关键词：
Hematopoietic Stem Cell Transplantation; Hyaluronidase; Child Health Questionnaire; Secondary Immunodeficiency; Immunoglobulin Substitution;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1307 / 1319
页数：12
相关论文
共 50 条
  • [21] Subcutaneous dextrose for rehydration of elderly patients - An evidence-based review
    Turner T.
    Cassano A.-M.
    BMC Geriatrics, 4 (1)
  • [22] Thrombosis Association with Administration of Intravenous Human Immunoglobulin in Patients with Primary or Secondary Immunodeficiencies
    Goncalves, Danilo Gois
    de Assis, Joao Paulo
    Sini, Bruno
    Marinho, Ana Karolina
    Kokron, Cristina Maria
    Grecco, Octavio
    Kalil, Jorge
    Barros, Myrthes Toledo
    JOURNAL OF CLINICAL IMMUNOLOGY, 2017, 37 : S55 - S55
  • [23] Population pharmacokinetics of immunoglobulin G after intravenous, subcutaneous, or hyaluronidase-facilitated subcutaneous administration in immunoglobulin-naive patients with primary immunodeficiencies
    Li, Zhaoyang
    Follman, Kristin
    Freshwater, Ed
    Engler, Frank
    Yel, Leman
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 128
  • [24] Immunoglobulin replacement therapy for primary immunodeficiencies
    Peter, Jonathan G.
    Chapel, Helen
    IMMUNOTHERAPY, 2014, 6 (07) : 853 - 869
  • [25] Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies
    Paris, Kenneth
    Haddad, Elie
    Borte, Michael
    Brodszki, Nicholas
    Derfalvi, Beata
    Marodi, Laszlo
    Hussain, Iftikhar
    Darter, Amy
    Engl, Werner
    Leibl, Heinz
    McCoy, Barbara
    Yel, Leman
    IMMUNOTHERAPY, 2019, 11 (05) : 397 - 406
  • [26] Overview of subcutaneous immunoglobulin 16.5% in primary and secondary immunodeficiency diseases
    Kobayashi, Roger H.
    Litzman, Jiri
    Rizvi, Syed
    Kreuwel, Huub
    Hoeller, Sonja
    Gupta, Sudhir
    IMMUNOTHERAPY, 2022, 14 (04) : 259 - 270
  • [27] Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies
    Li, Zhaoyang
    Follman, Kristin
    Freshwater, Ed
    Engler, Frank
    Yel, Leman
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 113
  • [28] Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study (vol 18, 70, 2022)
    Keith, Paul K. K.
    Cowan, Juthaporn
    Kanani, Amin
    Kim, Harold
    Lacuesta, Gina
    Lee, Jason K. K.
    Chen, Jie
    Park, Michelle
    Gladiator, Andre
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2023, 19 (01):
  • [29] A systematic evidence-based review of treatments for primary hyperhidrosis
    Stuart, Michael E.
    Strite, Sheri A.
    Gillard, Kristin Khalaf
    JOURNAL OF DRUG ASSESSMENT, 2021, 10 (01) : 35 - 50
  • [30] Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study
    Michael Borte
    Leif G. Hanitsch
    Nizar Mahlaoui
    Maria Fasshauer
    Dörte Huscher
    Matthaios Speletas
    Maria Dimou
    Marta Kamieniak
    Corinna Hermann
    David Pittrow
    Cinzia Milito
    Journal of Clinical Immunology, 2023, 43 : 1259 - 1271
12345